BRANDERLY MALIWA: Open Payments
NPI 1447790530 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 17 payments from 5 companies in 2025. Trend: 2023 $291 · 2024 $133 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $150 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| ABBVIE INC. | 2 | $27 |
| Lilly USA, LLC | 1 | $17 |
Products named: FANAPT, Rybelsus, CAPLYTA, ZEPBOUND, Ozempic, VRAYLAR, UBRELVY, Wegovy.
Industry payments across GA — which companies pay providers there.
